New Findings from Hunan Cancer Hospital in the Area of Lung Cancer Described [Camrelizumab Combined With Apatinib and Nanoparticle Albumin-bound Paclitaxel In Lung Adenocarcinoma (Capap-lung): a Single-arm Phase Ii Study]

Press/Media

Period27 Feb 2024

Media coverage

1

Media coverage

  • TitleNew Findings from Hunan Cancer Hospital in the Area of Lung Cancer Described [Camrelizumab Combined With Apatinib and Nanoparticle Albumin-bound Paclitaxel In Lung Adenocarcinoma (Capap-lung): a Single-arm Phase Ii Study]
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date27/02/24
    PersonsJie Lin